Clinical Trials
7 trialsNCT05093387 2022-11-15
SGT-53, Carboplatin, and Pembrolizumab for the Treatment of Metastatic Triple Negative Inflammatory Breast Cancer
Northwestern University
Phase 1 Withdrawn
NCT02227082 2021-08-04
Olaparib and Radiotherapy in Inoperable Breast Cancer
The Netherlands Cancer Institute
Phase 1 Completed
NCT00004261 2018-02-22
EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma
University Health Network, Toronto
Phase 1 Terminated
NCT00346229 2016-03-22
Temperature-Sensitive Liposomal Doxorubicin and Hyperthermia in Treating Women With Locally Recurrent Breast Cancer
Duke University
Phase 1 Terminated
NCT01880385 2013-06-19
Beva
Association Tunisienne de lutte Contre le Cancer
Phase 1 Unknown
NCT00004604 2013-02-22
Biological Therapy in Treating Patients With Metastatic Cancer
Duke University
Phase 1 Completed
NCT00005822 2010-06-11
SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer
Case Comprehensive Cancer Center
Phase 1 Completed